76 results
6-K
EX-99.1
PRTG
Portage Biotech Inc
18 Jan 24
Current report (foreign)
5:09pm
clinical data reads over next 2 years* Engine for Efficient Drug Development & Commercialization Expert scientific oversight Lean structure … for commercialization/acquisition Expert Leadership with Track Record of Success Proven success, more than 10 oncology approvals Formation of Biohaven Pharmaceuticals
6-K
EX-99.1
PRTG
Portage Biotech Inc
6 Mar 24
Current report (foreign)
9:11pm
reads over next 2 years* Engine for Efficient Drug Development & Commercialization Expert scientific oversight Lean structure with financial flexibility … /acquisition Expert Leadership with Track Record of Success Proven success, more than 10 oncology approvals Formation of Biohaven Pharmaceuticals, sale
6-K
EX-99.2
PRTG
Portage Biotech Inc
7 Jul 22
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway
8:30am
the next 2 years De - risked Research & Development Approach Expert scientific oversight Fast follower strategy Positioned as preferred partner for pharma … investment Packaged for commercialization/ acquisition Expert Leadership with Track Record of Success Proven success with early investment, 5 onc approvals, formation of Biohaven Pharmaceuticals 12
424B3
PRTG
Portage Biotech Inc
6 Mar 24
Prospectus supplement
9:36pm
capital investment Five potential phase 1b/2 clinical data reads over next 2 years* Engine for Efficient Drug Development & Commercialization Expert … pharma and biotech Packaged for commercialization/acquisition Expert Leadership with Track Record of Success Proven success, more than 10 oncology
6-K/A
EX-1
PRTG
Portage Biotech Inc
27 Jan 11
Bontan Provides Updates on Shaldieli Dispute
12:00am
were supported with affidavits and expert opinions. After the Parties had agreed to waive the examination of the affiants and expert witnesses, and after
424B3
9zrfxn
18 Jan 24
Prospectus supplement
5:41pm
6-K
EX-99.1
r7difshq
20 Jun 23
Current report (foreign)
5:53pm
6-K
EX-99.1
wt4qa v01mwx9
1 May 23
Current report (foreign)
8:00am
6-K
EX-99.1
b6l8x728apjyagcz1
14 Sep 22
Current report (foreign)
10:31am
6-K
EX-99.1
7cv23tah7vckzo250
13 Nov 23
Current report (foreign)
6:10am
6-K
EX-99.1
kmokpu4ireomgtva7f
14 Aug 23
Current report (foreign)
4:52pm
6-K
EX-99.1
go0unzh hxii
30 Nov 22
Current report (foreign)
9:08pm
424B3
ha0na izmng
14 Nov 23
Prospectus supplement
6:00am
6-K
EX-99.1
5n2ixcnaa bf6rjc97e
8 Sep 23
Current report (foreign)
4:01pm
6-K
EX-5.2
v4x 4adby
3 Oct 23
Current report (foreign)
4:05pm
6-K
EX-1
f5cpn0me2j
18 Jan 11
Israeli Court Lifts Temporary Injunction Against Shaldieli Transaction Bontan Has Filed an Application for Leave to Appeal
12:00am
6-K
onthep
7 Jan 14
Portage Acquires Majority Interest In Biohaven Pharmaceutical Holding Company Limited
12:00am
424B3
xbne4o39rpkmh9bc 5c4
7 Jan 14
Prospectus supplement
12:00am
424B3
dgjges2tohz66
7 Jan 14
Prospectus supplement
12:00am